Total Payments
$406,087
2024 Payments
$172,184
Companies
15
Transactions
402
Medicare Patients
240
Medicare Billing
$24,985
Payment Breakdown by Category
Other$301,347 (74.2%)
Consulting$53,338 (13.1%)
Travel$39,996 (9.8%)
Food & Beverage$11,407 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $282,772 | 84 | 69.6% |
| Consulting Fee | $53,338 | 15 | 13.1% |
| Travel and Lodging | $39,996 | 110 | 9.8% |
| Honoraria | $18,575 | 4 | 4.6% |
| Food and Beverage | $11,407 | 189 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $214,866 | 158 | $0 (2024) |
| Biogen, Inc. | $106,104 | 106 | $0 (2024) |
| TG Therapeutics, Inc. | $23,356 | 36 | $0 (2024) |
| Horizon Therapeutics plc | $22,490 | 36 | $0 (2023) |
| Amgen Inc. | $18,649 | 19 | $0 (2024) |
| Genentech USA, Inc. | $9,020 | 10 | $0 (2023) |
| GENZYME CORPORATION | $7,592 | 12 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $2,481 | 4 | $0 (2022) |
| Celgene Corporation | $589.30 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $515.48 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $172,184 | 123 | EMD Serono, Inc. ($124,649) |
| 2023 | $155,152 | 170 | EMD Serono, Inc. ($89,333) |
| 2022 | $73,587 | 90 | Biogen, Inc. ($62,218) |
| 2021 | $2,601 | 5 | GENZYME CORPORATION ($2,260) |
| 2020 | $2,004 | 4 | Genentech USA, Inc. ($1,865) |
| 2019 | $542.06 | 9 | Novartis Pharmaceuticals Corporation ($182.83) |
| 2018 | $17.69 | 1 | EMD Serono, Inc. ($17.69) |
All Payment Transactions
402 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Immunology | ||||||
| 12/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,110.00 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $91.08 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Biogen, Inc. | TYSABRI (Biological) | Travel and Lodging | Cash or cash equivalent | $31.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,843.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/01/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | Cash or cash equivalent | $293.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $98.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| 11/20/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: Immunology | ||||||
| 11/08/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $256.51 | General |
| Category: Neurology | ||||||
| 11/08/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $73.23 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $68.36 | General |
| Category: Neurology | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $274.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $617.93 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 78 | 96 | $25,275 | $8,062 |
| 2022 | 4 | 122 | 126 | $50,996 | $10,608 |
| 2021 | 2 | 40 | 40 | $27,258 | $6,315 |
Total Patients
240
Total Services
262
Medicare Billing
$24,985
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 55 | $12,155 | $4,066 | 33.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 36 | 41 | $13,120 | $3,996 | 30.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 27 | 27 | $12,371 | $2,962 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 23 | $13,115 | $2,647 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 21 | $5,811 | $1,542 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $6,618 | $1,118 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $5,611 | $973.20 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 18 | $4,512 | $852.74 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $2,958 | $512.02 | 17.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $12,198 | $2,943 | 24.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 12 | 12 | $9,096 | $1,918 | 21.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $5,964 | $1,454 | 24.4% |
About Dr. Tyler Kaplan, M.D
Dr. Tyler Kaplan, M.D is a Neurology healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2015. The National Provider Identifier (NPI) number assigned to this provider is 1861887358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tyler Kaplan, M.D has received a total of $406,087 in payments from pharmaceutical and medical device companies, with $172,184 received in 2024. These payments were reported across 402 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($282,772).
As a Medicare-enrolled provider, Kaplan has provided services to 240 Medicare beneficiaries, totaling 262 services with total Medicare billing of $24,985. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Maywood, IL
- Active Since 04/01/2015
- Last Updated 09/18/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861887358
Products in Payments
- Mavenclad (Drug) $97,030
- MAVENCLAD (Drug) $87,281
- TYSABRI (Biological) $45,973
- VUMERITY (Drug) $40,983
- UPLIZNA (Drug) $22,490
- BRIUMVI (Drug) $18,815
- Tysabri (Biological) $14,024
- UPLIZNA (Biological) $12,049
- Ocrevus (Biological) $7,139
- OCREVUS (Biological) $1,856
- ZEPOSIA (Drug) $589.30
- KESIMPTA (Drug) $332.65
- Mavenclad (Biological) $165.17
- BOTOX (Drug) $145.41
- ULTOMIRIS (Biological) $121.91
- MAYZENT (Drug) $115.70
- PURIFIED CORTROPHIN GEL (Drug) $74.72
- GILENYA (Drug) $67.13
- AJOVY (Drug) $48.65
- Ponvory (Drug) $32.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Maywood
Dr. Rima Dafer, Md, Mph, MD, MPH
Neurology — Payments: $114,467
Neurology $114,467
Dr. Antonio Iglesias, M.d, M.D
Neurology — Payments: $7,738
Neurology $7,738
Rukmaiah Bhupalam, Md, MD
Neurology — Payments: $7,389
Neurology $7,389
Dr. Jigisha Thakkar, M.b.b.s, M.B.B.S
Neurology — Payments: $6,485
Neurology $6,485
Dr. Brandon Bond, M.d, M.D
Neurology — Payments: $6,052
Neurology $6,052
Jose Biller, Md, MD
Neurology — Payments: $3,610
Neurology $3,610